Summer 2026 - Informatics and Predictive Sciences Internship at Bristol-Myers Squibb

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Drug DiscoveryIndustries

Requirements

Currently enrolled in a Ph.D. program in computer sciences, physics, bioinformatics, computational biology or a related field
Experiences in agentic frameworks (e.g. LangChain, LangGraph)
Experiences in developing LLM-powered tools (e.g. Chatbot, SQL agent, RAG) and/or deep learning (e.g. PyTorch, TensorFlow)
Experiences in genomics data analyses are a plus and not required
Must be able to work full-time for the program duration
Excellent communication and presentation skills
All candidates must be authorized to work in the US both at the time of hire and for the duration of their employment (no immigration or visa sponsorship available)

Responsibilities

Curate and index processed genomic datasets (e.g., gene expression tables, chromatin binding signals, genome-wide CRISPR hits) to make them compatible with LLM-based learning and querying
Design and implement agentic frameworks to streamline biological insight extraction and interpretation
Develop interactive web-based tools (e.g., local servers, R Shiny apps) to support data visualization and cross-functional communication
Effectively communicate and present findings to multidisciplinary teams

Skills

Machine Learning

Large Language Models

Agentic Architectures

Functional Genomics

Omics Data

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free